Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Sep;44(10):1179-1197.
doi: 10.1002/pd.6623. Epub 2024 Aug 13.

Prenatal exome sequencing, a powerful tool for improving the description of prenatal features associated with genetic disorders

Affiliations

Prenatal exome sequencing, a powerful tool for improving the description of prenatal features associated with genetic disorders

Christel Thauvin-Robinet et al. Prenat Diagn. 2024 Sep.

Abstract

Objective: Prenatal exome sequencing (pES) is now commonly used in clinical practice. It can be used to identifiy an additional diagnosis in around 30% of fetuses with structural defects and normal chromosomal microarray analysis (CMA). However, interpretation remains challenging due to the limited prenatal data for genetic disorders.

Method: We conducted an ancillary study including fetuses with pathogenic/likely pathogenic variants identified by trio-pES from the "AnDDI-Prenatome" study. The prenatal phenotype of each patient was categorized as typical, uncommon, or unreported based on the comparison of the prenatal findings with documented findings in the literature and public phenotype-genotype databases (ClinVar, HGMD, OMIM, and Decipher).

Results: Prenatal phenotypes were typical for 38/56 fetuses (67.9%). For the others, genotype-phenotype associations were challenging due to uncommon prenatal features (absence of recurrent hallmark, rare, or unreported). We report the first prenatal features associated with LINS1 and PGM1 variants. In addition, a double diagnosis was identified in three fetuses.

Conclusion: Standardizing the description of prenatal features, implementing longitudinal prenatal follow-up, and large-scale collection of prenatal features are essential steps to improving pES data interpretation.

Trial registration: ClinicalTrials.gov NCT03964441.

PubMed Disclaimer

References

REFERENCES

    1. Liu L, Oza S, Hogan D, et al. Global, regional, and national causes of child mortality in 2000‐13, with projections to inform post‐2015 priorities: an updated systematic analysis. Lancet. 2015;385(9966):430‐440. https://doi.org/10.1016/s0140‐6736(14)61698‐6
    1. Hillman SC, McMullan DJ, Hall G, et al. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta‐analysis. Ultrasound Obstet Gynecol. 2013;41(6):610‐620. https://doi.org/10.1002/uog.12464
    1. Mellis R, Oprych K, Scotchman E, Hill M, Chitty LS. Diagnostic yield of exome sequencing for prenatal diagnosis of fetal structural anomalies: a systematic review and meta‐analysis. Prenat Diagn. 2022;42(6):662‐685. https://doi.org/10.1002/pd.6115
    1. Tran Mau‐Them F, Delanne J, Denommé‐Pichon AS, et al. Prenatal diagnosis by trio exome sequencing in fetuses with ultrasound anomalies: a powerful diagnostic tool. Front Genet. 2023;14:1099995. https://doi.org/10.3389/fgene.2023.1099995
    1. Normand EA, Braxton A, Nassef S, et al. Clinical exome sequencing for fetuses with ultrasound abnormalities and a suspected Mendelian disorder. Genome Med. 2018;10(1):74. https://doi.org/10.1186/s13073‐018‐0582‐x

Publication types

Associated data

Grants and funding